Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1

Conditions

Melanoma 2Peritoneal Neoplasms 1Carcinoma, Transitional Cell 1

Interventions

Hyperthermic Intraperitoneal Chemotherapy 27Cisplatin 17Oxaliplatin 16Cytoreduction Surgical Procedures 15Paclitaxel 12Fluorouracil 10Mitomycin 8Leucovorin 8Doxorubicin 7Docetaxel 5Neoadjuvant Therapy 4Blood Specimen Collection 4Taxes 3Surgical Procedures, Operative 3Chemotherapy, Adjuvant 3Carboplatin 3Bevacizumab 3catumaxomab 2Platinum 2Palliative Care 2Observation 2Nivolumab 2Mitozytrex 2Laparoscopy 2Interviews as Topic 2Indocyanine Green 2Folfox protocol 2Albumin-Bound Paclitaxel 21,2-diaminocyclohexaneplatinum II citrate 2tremelimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Peritoneal Neoplasms × soluble LAG-3 protein, human × Clear all
NCT03252938 2026-02-19

INSIGHT

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Phase 1 Active not recruiting
83 enrolled
GenitourinaryGynecologic

Carcinoma, Transitional Cell, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡